A carregar...
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented effort toward the development of an effective and safe vaccine. Aided by extensive research efforts into characterizing and developing countermeasures towards prior coronavirus ep...
Na minha lista:
| Publicado no: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7733686/ https://ncbi.nlm.nih.gov/pubmed/33316346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2020.12.006 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|